(+/-) Clopidogrel hydrogensulfate, >=98% (HPLC), powder

Code: c0614-5mg D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Inhibits ADP-induced platelet aggregation; anti-thrombotic drug.

Features and Benefits

This compound was developed by Bri...


read more

Your Price
$303.02 5MG
REQUEST

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Inhibits ADP-induced platelet aggregation; anti-thrombotic drug.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the P2 Receptors: P2Y G-Protein Family page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Packaging

Store under desiccant

5, 25 mg in glass bottle

assay≥98% (HPLC)
colorwhite
formpowder
InChI keyFDEODCTUSIWGLK-UHFFFAOYSA-N
InChI1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)
originatorBristol-Myers Squibb
Quality Level100
SMILES stringOS(O)(=O)=O.COC(=O)C(N1CCc2sccc2C1)c3ccccc3Cl
solubilityDMSO: ~26 mg/mL
storage conditiondesiccated
storage temp.2-8°C
Code
Description
Unit Size
List Price
Qty
C0614-25MG
(+/-) Clopidogrel hydrogensulfate, >=98% (HPLC), powder

Unit:25MG
List Price: $1,041.56
Source:List Price
ADD
Cas Number135046-48-9
This product has met the following criteria: